Table 2.
The association between sentinel variants representing each lung cancer locus and lung cancer risk.
Strata | Locus* | rs number | Gene | Allelea | Imputed versus Oncoarray genotyped | Candidate Oncoarray | EAF | OR | 95%CI | P-value | CPD | FTND | FEV1 | FVC | FEV1/FVC |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Customized panel | p- value | p- value | p- value | p- value | p- value | ||||||||||
Lung | 1p31.1* | rs71658797 | FUBP1 | T_A | Oncoarray | No | 0.103 | 1.1 | 1.09–1.18 | 3.3E-11 | 0.056 | 0.334 | 0.445 | 0.898 | 0.334 |
Lung | 6q27* | rs6920364 | RNASET2 | G_C | Imputed | eQTL | 0.456 | 1.1 | 1.05–1.10 | 1.3E-08 | 0.833 | 0.104 | 0.927 | 0.876 | 0.986 |
Lung | 8p21.1* | rs11780471 | CHRNA2 | G_A | Imputed | Lung | 0.060 | 0.9 | 0.83–0.91 | 1.7E-08 | 0.646 | 0.403 | 6.9E-04 | 0.055 | 0.016 |
Lung | 13q13.1 | rs11571833 | BRCA2 | A_T | Imputed | Lung | 0.011 | 1.6 | 1.43–1.80 | 6.1E-16 | 0.890 | 0.312 | 0.601 | 0.667 | 0.237 |
Lung | 15q21.1* | rs66759488 | SEMA6D | G_A | imputed | Lung | 0.362 | 1.1 | 1.05–1.10 | 2.8E-08 | 0.266 | 0.888 | 0.739 | 0.200 | 0.202 |
Lung | 15q25.1 | rs55781567 | CHRNA5 | C_G | Imputed | Lung | 0.367 | 1.3 | 1.27–1.33 | 3.1E-103 | 6.8E-38 | 9.7E-16 | 7.2E-03 | 0.020 | 0.144 |
Lung | 19q13.2ˆ | rs56113850 | CYP2A6 | C_T | Oncoarray | Lung | 0.440 | 0.9 | 0.86–0.91 | 5.0E-19 | 8.1E-20 | 7.5E-04 | 0.822 | 0.826 | 0.319 |
Adeno | 3q28 | rs13080835 | TP63 | G_T | Imputed | Lung | 0.493 | 0.9 | 0.87–0.92 | 7.5E-12 | 0.803 | 0.336 | 0.135 | 0.445 | 0.834 |
Adeno | 5p15.33 | rs7705526 | TERT | C_A | Oncoarray | All | 0.342 | 1.3 | 1.21–1.29 | 3.8E-35 | 0.511 | 0.738 | 0.292 | 0.038 | 0.657 |
Adeno | 8p12* | rs4236709 | NRG1 | A_G | Imputed | eQTL | 0.218 | 1.1 | 1.09–1.18 | 1.3E-10 | 0.991 | 0.957 | 0.503 | 0.151 | 0.403 |
Adeno | 9p21.3* | rs885518 | CDNK2A | A_G | Imputed | Several | 0.101 | 1.2 | 1.11–1.23 | 9.96E-10 | 0.904 | 0.321 | 0.421 | 0.096 | 0.146 |
Adeno | 10q24.3* | rs11591710 | OBFC1 | A_C | Imputed | Lung | 0.137 | 1.2 | 1.11–1.22 | 6.3E-11 | 0.500 | 0.152 | 0.027 | 0.019 | 0.533 |
Adeno | 11q23.3* | rs1056562 | AMICA1 | C_T | Oncoarray | Breast | 0.473 | 1.1 | 1.07–1.14 | 2.8E-10 | 0.717 | 0.538 | 0.449 | 0.718 | 0.039 |
Adeno | 15q21.1* | rs77468143 | SECISBP2L | T_G | Imputed | No | 0.253 | 0.9 | 0.83–0.89 | 1.7E-16 | 0.071 | 0.184 | 4.9E-03 | 0.440 | 1.4E-03 |
Adeno | 20q13.33* | rs41309931 | RTEL1 | G_T | Imputed | Prost/ColR | 0.117 | 1.2 | 1.11–1.23 | 1.3E-09 | 0.146 | 0.939 | 0.964 | 0.657 | 0.284 |
SQC | 6p21.33 | rs116822326 | MHC | A_G | Imputed | Lung | 0.155 | 1.3 | 1.19–1.32 | 3.8E-19 | 0.392 | 0.774 | 0.132 | 0.498 | 0.103 |
SQC | 12p13.33 | rs7953330 | RAD52 | G_C | Oncoarray | Lung | 0.315 | 0.9 | 0.83–0.90 | 7.3E-13 | 0.800 | 0.463 | 0.019 | 3.3E-03 | 0.424 |
SQC | 22q12.1 | rs17879961 | CHEK2 | A_G | Oncoarray | Lung | 0.005 | 0.4 | 0.32–0.52 | 5.7E-13 | 0.441 | 0.360 | 0.041 | 0.040 | 0.805 |
denote novel locus identified to GWAS significance by this study; a, reference_effect. Bolded p-values indicate significant associations with consistent direction as expected. Genome positions relative to GRCh37, EAF, effective allele frequency; OR, odds (log additive) ratio; 95%CI, 95% confidence interval. P-value, based on fixed-effect meta-analysis adjusted for age, sex and genetically derived ancestry; CPD, cigarette per day; FTND, Fagerstrӧm Test for Nicotine Dependence; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.
Adeno, adenocarcinoma; SQC, squamous cell carcinoma.
marker had an acceptable, but not ideal concordance rate (see Supplementary Note)